Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation
Background Hepatoblastoma (HB) is a rare malignancy usually occurring in children under 3 years old. With advancements in surgical techniques and molecular biology, new treatments have been developed.Data resources The recent literatures on new treatments, molecular mechanisms and clinical trials fo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-07-01
|
| Series: | World Journal of Pediatric Surgery |
| Online Access: | https://wjps.bmj.com/content/4/3/e000220.full |